THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

are aged 50 and over and have asked your GP for a test Doctors also check your PSA level as you go through prostate cancer treatment. It can help them see how well treatment is working. Prostate ...

The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

A new blood test for prostate cancer that offers greater accuracy than prostate-specific antigen (PSA) has been put to the test by researchers at the University of East Anglia (UEA) in collaboration ...

A Prostate-Specific Antigen (PSA) test is a procedure formed on men to detect prostate cancer. It is considered an effective means of cancer screening and can be used to monitor the effectiveness of ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.